Management
The management team is the number 1 success factor - with us as well.
Dr. Georg Lentzen
graduated as biochemist, Georg has more than 20 years of international experience in leading roles in the biotech industry.
As head of R&D teams in biotech companies in the UK, Germany and the Netherlands, he led the development of several successful biotech products from early concept to commercialization.
Peter Kallien
hold a degree in business administration and is an expert in business model development and financing of innovative companies.
In 1992, he was co-founder and managing director of a consulting company, which supports physicians and pharmacists in setting up their own businesses.
Dr. Cornelia Bähr
is a bioprocess engineer with more than 10 years of experience in bioprocess development.
M.Sc. Marie Kappen
is a nanobiotechnologist and has acquired a broad knowledge of natural sciences and engineering through her interdisciplinary studies in bio- and nanotechnologies and her master's thesis at the Paul Ehrlich Institute.
Management
Dr. Georg Lentzen
graduated as biochemist, Georg has more than 20 years of international experience in leading roles in the biotech industry. As head of R&D teams in biotech companies in the UK, Germany and the Netherlands, he led the development of several successful biotech products from early concept to commercialization. Before joining b.value AG, Georg was Director R&D at Isobionics BV (Netherlands), where he led the development of a biotech platform for terpene-based flavor & fragrance ingredients. Earlier in his career, as CSO of bitop AG (Germany), he contributed significantly to developing the company into a provider of high-value products for health care, life science and cosmetics. As Managing Director of b.value AG, he works on identifying and supporting start-ups and founders that combine technical excellence with outstanding entrepreneurship.
Further activities:
- Lecturer for the course “Metabolic Engineering” at Rhine-Waal University of Applied Sciences
Management
Peter Kallien
hold a degree in business administration and is an expert in business model development and financing of innovative companies. In 1992, he was co-founder and managing director of a consulting company, which supports physicians and pharmacists in setting up their own businesses.In 1996, he moved to the Private University of Witten/Herdecke. During his ten years as Managing Director, he was involved in the successful establishment of approximately 15 start-ups originating from the university.
Together with Thomas Schwarz and Gerhard Schembecker, he founded b.experts GmbH in 2013 and b.value AG in 2016, where he is a member of the Management Board.
He has been operationally involved in the implementation of numerous successful start-ups. Mr. Kallien was a long-time member of the supervisory boards of cardiac research GmbH in Dortmund and of bitop AG in Witten.
Further activities:
- 1999-2005: Founder and CEO of Biotechnology Ruhrgebiet Aktiengesellschaft (bioRuhr AG) (small privately financed VC company)
- 2010: Founder and Managing Director of apeer GmbH: Innovation financing of start-ups and SMEs
- 2011-2015: CFO of InstrAction GmbH
- Since 2007 Chairman of the Supervisory Board of ISR Information Products AG (Braunschweig)
Investment manager
Dr. Cornelia Bähr
is a bioprocess engineer with more than 10 years of experience in bioprocess development. For more than 5 years she was active as a scientific consultant in the cluster and association environment of industrial biotechnology and chemistry (CLIB2021 and VCI.NRW), where she was involved in the development and commercialization of biotechnological processes and their products.
Since August 2017, Dr. Bähr has been contributing her technical expertise and experience in international project management as project and interim director to the Company Building of b.experts GmbH.